InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Robinson Chandler, Chief Executive Officer. Director active across 1 company, notably Monopar Therapeutics. In total, 26 disclosures have been recorded. Activity tracked since 28 May 2024. The latest transaction was filed on 31 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Robinson Chandler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
6,732 sharesCommon StockSEC:0001437749-26-011079:0
1,972 shares@ US$54.7999.9% of flowCommon StockSEC:0001437749-26-011079:1
62,815 shares0Common StockSEC:0001437749-26-002527:0
8,724 sharesCommon StockSEC:0001437749-26-000306:0
8,726 sharesCommon StockSEC:0001437749-25-030284:0
16,800 shares@ US$0.0050.1% of flowCommon StockSEC:0001437749-25-022861:0
13,344 sharesCommon StockSEC:0001437749-25-021994:0
4,106 sharesCommon StockSEC:0001437749-25-010809:0
6,002 sharesCommon StockSEC:0001437749-25-006736:0
4,895 sharesCommon StockSEC:0001437749-25-000096:0
4,895 sharesCommon StockSEC:0001437749-24-030536:0
24,476 sharesCommon StockSEC:0001437749-24-022023:0
84,000 shares@ US$0.001100.0% of flowCommon StockSEC:0001437749-24-018775:0
24,474 sharesCommon StockSEC:0001437749-24-010721:0
24,474 sharesCommon StockSEC:0001437749-24-000482:0
24,474 sharesCommon StockSEC:0001437749-23-027588:0
35,039 sharesCommon StockSEC:0001437749-23-019257:0
13,911 sharesCommon StockSEC:0001437749-23-009332:0
13,912 sharesCommon StockSEC:0001437749-23-000160:0
13,911 sharesCommon StockSEC:0001654954-22-013280:0
23,882 sharesCommon StockSEC:0001654954-22-009138:0
3,941 sharesCommon StockSEC:0001654954-22-004491:0
3,941 sharesCommon StockSEC:0001654954-22-000124:0
6,724 sharesCommon StockSEC:0001654954-22-000126:0
3,941 sharesCommon StockSEC:0001654954-21-010715:0
25 of 26 declarations
About Robinson Chandler
Robinson Chandler is Directeur Général and is linked to Monopar Therapeutics, where he is Chief Executive Officer. He has 26 filings in total, and in the sample of recent filings covering the period from 2021-07-02 to 2026-04-02, the most frequent transaction nature is Levée d'options. The buy and sell volumes shown for that sample are both EUR 0.
